This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Rheumatology
Biosimilar adalimumab and infliximab accepted for regulatory review by the EMA
Read more
Proposed rituximab and etanercept biosimilars recommended for approval in Europe
Read more
NRAS launches video to help raise awareness of new developments in treatment
Read more
First biosimilar mAb in oncology is granted EU marketing authorisation
Read more
Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review
Read more
Guselkumab shows promise in Phase II trial for the treatment of psoriatic arthritis
Read more
Certolizumab pegol (Cimzia®) AutoClicks® Prefilled Pen now available on NHS
Read more
Certolizumab pegol (Cimzia®) AutoClicks® Prefilled Pen now available on NHS
Read more
Results from NOR-SWITCH study support switch from Remicade® to Remsima®
Read more
EMA acceptance for review of marketing authorisation application for sarilumab
Read more
Sandoz’s biosimilar etanercept has equivalent efficacy to originator product
Read more
UCB’s bimekizumab demonstrates positive results in early development in patients with psoriatic arthritis
Read more
Merck initiates Phase III study of MSB11022 in chronic plaque psoriasis
Read more
Campaign to reduce delay in diagnosis for people with axial spondyloarthritis
Read more
NICE says ‘yes’ to new option for rheumatoid arthritis
Read more
Access to potentially life-changing rheumatoid arthritis treatments safeguarded by NICE
Read more
Novartis announces publication in The Lancet
Read more
Page 8 of 9
« First
«
...
5
6
7
8
9
»
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Ivacaftor use in cystic fibrosis ‘safe and effective’ from one month old, study finds
25 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: